NCT01801280
Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
See it on ClinicalTrials.gov ↗20 people
40%
60%
8 womenmiddle line = equal numbers12 men
- Phase
- PHASE4
- Paid for by
- Klemens Budde
- Finished
- 2014-03
- Health conditions
- Transplantation, Immunosuppression, Drug Interaction
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 44 y
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“pregnancy and/or lactation”
- No breastfeeding moms
Women who were breastfeeding could not join.
“pregnancy and/or lactation”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“women of childbearing potential must have a negative serum pregnancy test before study start and effective contraception must be used (method with PEARL index \<1%)”
Study titles and rules are shown in their original English.